Trial Details
UNKNOWNBasic Information
| Clinical ID | c228 |
|---|---|
| Identifier | NCT02027727 |
| Trial Title | Individualized Infiximab Dosing-Proof of Concept Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases |
| Interventions | OTHER: No Intervention |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-11-13 |
|---|---|
| Primary Completion Date | 2025-05-17 |
| Completion Date | 2025-03-18 |